News | March 15, 2023
Philips and Gibraltar Health Authority announce 16-year strategic partnership
Patients will no longer need to travel abroad for treatment of acute cardiac diseases
Patients will no longer need to travel abroad for treatment of acute cardiac diseases
A funding to expand operations and provide better patient care
Proposed combination enhances Pfizer’s position as a leading company in oncology
Dr. Hubbard brings more than 35 years of experience in the biopharmaceutical and pharma-tech services industries and CROs.
Open, scalable, end-to-end solution to improve diagnostic quality and efficiency
For the first-line treatment of patients with unresectable advanced or metastatic malignant pleural mesothelioma
Chronic Kidney Disease is a growing epidemic with 850 million people affected worldwide.
This new capability represents a significant shift from a microscope-based standard of care to the use of digital whole slide images
New GMP facility for clinical and small-scale commercial pharmaceutical lipids
The common stock of Concert will no longer be listed for trading on the Nasdaq Global Market
Subscribe To Our Newsletter & Stay Updated
